差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
Capital Com Australia Pty Ltd 澳大利亞（受 ASIC 監管） Capital Com UK Limited 由金融行為監管局 (FCA) 授權和監管 Capital Com SV Investments Limited 塞浦路斯/歐盟（受 CYSEC 監管） Сlosed Joint Stock Company «FinTech Solutions» （受 NBRB 監管） Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd 塞舌爾（受 FSA 監管） Capital Com Online Investments Ltd (Regulated by SCB) 我們的全球辦事處

掃碼下載 iOS 和安卓 APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Also you can contact us: call +44 2030978888 support@capital.com

交易 DiaMedica Therapeutics Inc. - DMAC CFD

1.5261
6.13%
  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.0978
多頭倉位隔夜費用

Long position overnight fee

Margin. Your investment $1,000.00
隔夜費用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
-0.024068%
空頭倉位隔夜費用

Short position overnight fee

Margin. Your investment $1,000.00
隔夜費用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
0.001846%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 1.438
開盤價* 1.3687
1 年變化* -50.23%
日範圍* 1.3686 - 1.5261
52 周範圍 1.12-2.81
平均交易量（10 天） 24.25K
平均交易量（3 個月） 788.43K
市值 42.04M
市盈率 -100.00K
流通股 26.44M
收入 N/A
EPS -0.50
股息（收益率 %） N/A
貝塔 1.76
下一個財報發布日期 Mar 28, 2023

所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開 高 低
Mar 24, 2023 1.5261 0.1576 11.52% 1.3685 1.5261 1.3684
Mar 23, 2023 1.4380 -0.1068 -6.91% 1.5448 1.5751 1.4380
Mar 22, 2023 1.5458 -0.0479 -3.01% 1.5937 1.6633 1.5454
Mar 21, 2023 1.6729 -0.0391 -2.28% 1.7120 1.7122 1.5843
Mar 20, 2023 1.6925 -0.0382 -2.21% 1.7307 1.7314 1.6529
Mar 17, 2023 1.7316 -0.0188 -1.07% 1.7504 1.7505 1.7010
Mar 16, 2023 1.8296 0.0891 5.12% 1.7405 1.8394 1.7405
Mar 15, 2023 1.6923 -0.0383 -2.21% 1.7306 1.7416 1.6820
Mar 14, 2023 1.7805 0.0878 5.19% 1.6927 1.8297 1.6422
Mar 13, 2023 1.6922 0.1276 8.16% 1.5646 1.7221 1.5646
Mar 10, 2023 1.6531 -0.0182 -1.09% 1.6713 1.7019 1.5645
Mar 9, 2023 1.6923 0.0502 3.06% 1.6421 1.7707 1.6421
Mar 8, 2023 1.7709 0.0994 5.95% 1.6715 1.7906 1.6715
Mar 7, 2023 1.7219 0.0798 4.86% 1.6421 1.7221 1.6421
Mar 6, 2023 1.7020 -0.0188 -1.09% 1.7208 1.7612 1.6723
Mar 3, 2023 1.7316 0.0790 4.78% 1.6526 1.7514 1.6526
Mar 2, 2023 1.7414 0.0300 1.75% 1.7114 1.7612 1.7114
Mar 1, 2023 1.7315 -0.0294 -1.67% 1.7609 1.7609 1.6428
Feb 28, 2023 1.6923 0.0502 3.06% 1.6421 1.7416 1.6421
Feb 27, 2023 1.6535 0.0099 0.60% 1.6436 1.7024 1.5842

DiaMedica Therapeutics Inc. Events

时间（协调世界时） (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2021 2020 2019 2018 2017
總收入 0 0 0 0.5 0
總營業費用 13.646 12.699 11.593 7.261 4.519
銷售/一般/行政費用，總計 4.881 4.389 3.693 2.739 1.313
研究與開發 8.765 8.31 7.9 4.522 3.206
Depreciation / Amortization
營業收入 -13.646 -12.699 -11.593 -6.761 -4.519
利息收入（費用），非經營淨值 0 -0.039 0.009
其他，淨值 0.082 0.434 0.975 1.146 0.25
稅前淨收入 -13.564 -12.265 -10.618 -5.654 -4.26
稅後淨收入 -13.592 -12.292 -10.649 -5.734 -4.26
未計算非常項目前的淨收益 -13.592 -12.292 -10.649 -5.734 -4.26
淨收入 -13.592 -12.292 -10.649 -5.734 -4.26
普通股股東可獲收益 (不含非經常性項目) -13.592 -12.292 -10.649 -5.734 -4.26
普通股股東可獲收益 (含非經常性項目) -13.592 -12.292 -10.649 -5.734 -4.26
攤薄淨收入 -13.592 -12.292 -10.649 -5.734 -4.26
攤薄後加權平均股 20.7734 15.6803 11.9877 7.74352 5.93579
扣除特別項目的每股攤薄盈利 -0.6543 -0.78391 -0.88833 -0.74049 -0.71768
每股正常攤薄盈利 -0.6543 -0.78391 -0.88833 -0.74049 -0.71768
收入 0 0.5 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
總收入 0 0 0 0 0
總營業費用 3.536 3.246 3.416 3.365 3.619
銷售/一般/行政費用，總計 1.562 1.375 1.084 1.209 1.213
研究與開發 1.974 1.871 2.332 2.156 2.406
營業收入 -3.536 -3.246 -3.416 -3.365 -3.619
其他，淨值 0.035 0.007 -0.027 0.098 0.004
稅前淨收入 -3.501 -3.239 -3.443 -3.267 -3.615
稅後淨收入 -3.508 -3.246 -3.45 -3.274 -3.622
未計算非常項目前的淨收益 -3.508 -3.246 -3.45 -3.274 -3.622
淨收入 -3.508 -3.246 -3.45 -3.274 -3.622
普通股股東可獲收益 (不含非經常性項目) -3.508 -3.246 -3.45 -3.274 -3.622
普通股股東可獲收益 (含非經常性項目) -3.508 -3.246 -3.45 -3.274 -3.622
攤薄淨收入 -3.508 -3.246 -3.45 -3.274 -3.622
攤薄後加權平均股 26.4431 26.5021 19.0357 18.7862 18.7667
扣除特別項目的每股攤薄盈利 -0.13266 -0.12248 -0.18124 -0.17428 -0.193
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 -0.13266 -0.12248 -0.18124 -0.17428 -0.193
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流動資産總額 45.439 27.921 8.836 17.972 1.494
現金和短期投資 45.112 27.507 7.878 16.823 1.353
Cash 4.707 7.409 3.883 16.823 1.353
應收賬款總額，淨額 0.13 0.34 0.823 0.78 0.08
Prepaid Expenses 0.084 0.064 0.047 0.369 0.061
Total Assets 45.551 28.095 9.053 18.339 1.802
Property/Plant/Equipment, Total - Net 0.112 0.174 0.217 0.096 0.037
Property/Plant/Equipment, Total - Gross 0.179 0.231 0.26
Accumulated Depreciation, Total -0.067 -0.057 -0.043
Total Current Liabilities 1.524 2.028 1.318 1.296 1.003
Accounts Payable 0.509 1.099 0.182
Accrued Expenses 1.011 0.923 1.13
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 0.084
Total Liabilities 1.527 2.081 1.436 1.314 1.003
Total Long Term Debt 0.003 0.007 0.013 0.018 0
Other Liabilities, Total 0 0.046 0.105
Total Equity 44.024 26.014 7.617 17.025 0.799
Common Stock 0 0 0 0 0
Additional Paid-In Capital 126.576 94.925 64.232 62.993 41.033
Retained Earnings (Accumulated Deficit) -82.501 -68.909 -56.617 -45.968 -40.234
Other Equity, Total -0.051 -0.002 0.002
Total Liabilities & Shareholders’ Equity 45.551 28.095 9.053 18.339 1.802
Total Common Shares Outstanding 26.4431 18.7462 12.0069 11.9569 6.37066
Accounts Receivable - Trade, Net 0.13 0.78 0.08
Other Long Term Assets, Total 0 0.271 0.271
Payable/Accrued 1.291 0.919
Current Port. of LT Debt/Capital Leases 0.004 0.006 0.006 0.005 0
Capital Lease Obligations 0.003 0.007 0.013 0.018 0
短期投資 40.405 20.098 3.995
Other Current Assets, Total 0.113 0.01 0.088
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 42.111 45.439 48.537 21.629 24.195
現金和短期投資 41.047 45.112 48.097 21.295 23.401
Cash 3.032 4.707 16.219 2.228 3.329
短期投資 38.015 40.405 31.878 19.067 20.072
應收賬款總額，淨額 0.168 0.13 0.104 0.016 0.337
Prepaid Expenses 0.793 0.084 0.336 0.318 0.457
Total Assets 42.211 45.551 48.664 21.774 24.356
Property/Plant/Equipment, Total - Net 0.1 0.112 0.127 0.145 0.161
Property/Plant/Equipment, Total - Gross 0.162 0.179 0.187 0.199 0.209
Accumulated Depreciation, Total -0.062 -0.067 -0.06 -0.054 -0.048
Total Current Liabilities 1.434 1.524 1.624 1.44 1.178
Accounts Payable 0.433 0.509 0.699 0.239 0.689
Accrued Expenses 0.995 1.011 0.921 1.196 0.483
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.006 0.004 0.004 0.005 0.006
Total Liabilities 1.443 1.527 1.628 1.456 1.211
Total Long Term Debt 0.009 0.003 0.004 0.005 0.005
Capital Lease Obligations 0.009 0.003 0.004 0.005 0.005
Other Liabilities, Total 0 0 0.011 0.028
Total Equity 40.768 44.024 47.036 20.318 23.145
Common Stock 0 0 0 0 0
Additional Paid-In Capital 126.884 126.576 126.296 96.126 95.68
Retained Earnings (Accumulated Deficit) -86.009 -82.501 -79.255 -75.805 -72.531
Other Equity, Total -0.107 -0.051 -0.005 -0.003 -0.004
Total Liabilities & Shareholders’ Equity 42.211 45.551 48.664 21.774 24.356
Total Common Shares Outstanding 26.4431 26.4431 26.4392 18.7862 18.7862
Accounts Receivable - Trade, Net 0.166 0.13
Other Current Assets, Total 0.103 0.113
  • 年度
  • 每季度
2021 2020 2019 2018 2017
淨收入/起跑線 -13.592 -12.292 -10.649 -5.734 -4.26
經營活動産生的現金 -12.252 -9.185 -9.102 -5.696 -3.9
經營活動産生的現金 0.024 0.021 0.021 0.015 0.004
非現金物品 1.777 1.891 1.139 0.659 0.4
已付現金利息 0.002 0.002
營運資金的變化 -0.461 1.195 0.387 -0.636 -0.044
投資活動産生的現金 -20.537 -16.134 -3.908 -0.05 -0.022
資本支出 -0.022 -0.047 -0.002 -0.05 -0.022
融資活動産生的現金 30.087 28.845 0.07 21.216 3.539
股票的發行（報廢），淨額 30.093 28.85 0.075 21.216 3.539
外彙效應
現金淨變化 -2.702 3.526 -12.94 15.47 -0.383
Cash Taxes Paid 0.028 0.036 0.026
其他投資現金流量項目，總計 -20.515 -16.087 -3.906
債務的發行（退還），淨額 -0.006 -0.005 -0.005
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -3.508 -13.592 -10.346 -6.896 -3.622
Cash From Operating Activities -3.888 -12.252 -9.448 -6.402 -4.313
Cash From Operating Activities 0.006 0.024 0.018 0.012 0.006
Non-Cash Items 0.443 1.777 1.354 1.023 0.551
Changes in Working Capital -0.829 -0.461 -0.474 -0.541 -1.248
Cash From Investing Activities 2.214 -20.537 -11.848 0.98 -0.009
Capital Expenditures 0 -0.022 -0.015 -0.013 -0.009
Other Investing Cash Flow Items, Total 2.214 -20.515 -11.833 0.993 0
Cash From Financing Activities -0.001 30.087 30.106 0.241 0.242
Issuance (Retirement) of Stock, Net 0 30.093 30.111 0.244 0.244
Issuance (Retirement) of Debt, Net -0.001 -0.006 -0.005 -0.003 -0.002
Net Change in Cash -1.675 -2.702 8.81 -5.181 -4.08
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
EQT Partners AB Private Equity 10.8 2855847 304827 2022-07-08 LOW
Trill AB,LLC. Corporation 9.6472 2551020 2551020 2021-09-28
Jacinto (Richard II) Individual Investor 9.4543 2500000 850947 2022-12-31 LOW
Lytton (Laurence W) Individual Investor 4.0539 1071970 -308296 2021-12-31 MED
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.961 782989 349 2022-12-31 LOW
Giuffre (Randall Michael) Individual Investor 1.4983 396184 35130 2023-01-03 LOW
Omega Advisors, Inc. Investment Advisor 1.1345 300000 100000 2021-12-31 LOW
Jacob Asset Management of New York, LLC Investment Advisor 0.8839 233730 -4770 2022-12-31 LOW
Pilnik (Richard D) Individual Investor 0.7937 209882 55555 2023-01-03 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6991 184870 -349 2022-12-31 LOW
Lynch (Timothy Patrick) Individual Investor 0.3792 100259 -100000 2022-12-31 LOW
Burroughs (Amy Louise) Individual Investor 0.2772 73288 17156 2023-01-03 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.2723 72012 2814 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.252 66629 0 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.2496 65997 1067 2022-12-31 LOW
Pauls (Dietrich John) Individual Investor 0.211 55804 20000 2022-11-16
Morgan Stanley & Co. LLC Research Firm 0.1672 44201 2194 2022-12-31 MED
Alcorn Harry W Jr Individual Investor 0.1663 43981 399 2022-03-22 MED
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.1612 42634 0 2022-12-31 LOW
Citadel Advisors LLC Hedge Fund 0.1483 39216 4304 2022-12-31 HIGH

為什麼選擇Capital.com？我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
打開

關閉

做空 做多
過往表現並非未來業績的可靠指標
盈利/虧損
Industry: Bio Therapeutic Drugs

301 Carlson Parkway
Suite 210
MINNEAPOLIS
MINNESOTA 55305
US

收入報表

  • Annual
  • Quarterly

人們也觀看

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
多頭倉位隔夜費用 -0.0194%
空頭倉位隔夜費用 -0.0025%
隔夜費時間 21:00 (UTC)
價差 0.03

XRP/USD

0.45 Price
-0.830% 1D Chg, %
多頭倉位隔夜費用 -0.0753%
空頭倉位隔夜費用 0.0069%
隔夜費時間 21:00 (UTC)
價差 0.00370

Gold

1,978.85 Price
-0.760% 1D Chg, %
多頭倉位隔夜費用 -0.0179%
空頭倉位隔夜費用 0.0097%
隔夜費時間 21:00 (UTC)
價差 0.30

US100

12,798.80 Price
+0.420% 1D Chg, %
多頭倉位隔夜費用 -0.0241%
空頭倉位隔夜費用 0.0018%
隔夜費時間 21:00 (UTC)
價差 3.0

還在尋找值得信賴的經紀商？

加入全球 500.000 多名交易者，選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易